Clinical Trials for NMIBC

Find clinical trials for nmibc. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

NCT ID: NCT06181266

This clinical trial is studying a new treatment called ZH9 for patients with a type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC). The trial is designed to test how safe and...

Recruiting

Phase: PHASE1 Type: interventional Locations: Myrtle Beach, South Carolina, United States, Hanover, Maryland, United States +3 more

A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

NCT ID: NCT06991868

This clinical trial is looking at a new way to monitor patients with different types of urinary tract cancers, specifically urothelial carcinoma. The goal is to see how effectively a test that dete...

Recruiting

Type: observational Locations: Beijing, Beijing, China

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT ID: NCT03914794

This clinical trial is studying a medication called Pemigatinib to see how well it works for patients with non-muscle invasive bladder cancer (NMIBC) who have had their tumors come back. The trial ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Washington, District Of Columbia, United States, Myrtle Beach, South Carolina, United States +4 more

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

NCT ID: NCT06800963

The ResQ133A-NMIBC trial is studying a new treatment using a type of bacteria called Recombinant Mycobacterium Bacillus Calmette-Guérin (rMBCG) for patients with non-muscle invasive bladder cancer ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Los Alamitos, California, United States, Glendale, California, United States

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

NCT ID: NCT06982690

This clinical trial is investigating the best way to use anesthesia during surgery for patients with a specific type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). The study a...

Not yet recruiting

Phase: NA Type: interventional Locations: Taipei, , Taiwan

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

NCT ID: NCT05014139

This clinical trial is studying a new treatment called enfortumab vedotin for patients with non-muscle invasive bladder cancer (NMIBC). NMIBC is a type of bladder cancer that hasn't spread into the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Orange, California, United States, Durham, North Carolina, United States +30 more

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

NCT ID: NCT06735287

This clinical trial is investigating new treatment options for patients with large non-muscle-invasive bladder cancer (NMIBC), specifically tumors that are 5 cm or larger. The goal is to find a way...

Recruiting

Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China

Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

NCT ID: NCT06889623

This clinical trial is studying the use of immediate chemotherapy right after surgery for patients with high-risk non-muscle-invasive bladder cancer (NMIBC). After surgery, some patients may still ...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

NCT ID: NCT06630871

This clinical trial is looking at a new treatment approach for patients with a specific type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) that is at high or very high risk of...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Fuzhou, Fujian, China

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

NCT ID: NCT06588179

This clinical trial is examining a new treatment for patients with high-risk non-muscle invasive bladder cancer (NMIBC) that cannot be fully removed using a common surgical method called transureth...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects

NCT ID: NCT05943379

This clinical trial is studying a new treatment option for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) who have not received prior BCG therapy or have not responded to it. In...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions